Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/2656
Title: Therapeutic applications of bioactive sphingolipids in hematological malignancies
Authors: Ekiz, Hüseyin Atakan
Baran, Yusuf
Ekiz, Hüseyin Atakan
Baran, Yusuf
Izmir Institute of Technology. Molecular Biology and Genetics
Keywords: Apoptosis
Bioactive sphingolipids
Drug resistance
Leukemia
Issue Date: Oct-2010
Publisher: John Wiley and Sons Inc.
Source: Ekiz, H. A., and Baran, Y. (2010). Therapeutic applications of bioactive sphingolipids in hematological malignancies. International Journal of Cancer, 127(7), 1497-1506. doi:10.1002/ijc.25478
Abstract: Sphingolipids are sphingosine-based lipid molecules that have important functions in cellular signal transduction and in a variety of cellular processes including proliferation, differentiation, programmed cell death (apoptosis) and responses to stressful conditions. Ceramides, dihydroceramide, sphingosine and sphingosine-1-phosphate are examples of those bioactive sphingolipids. They have a major impact on determination of the cell fate by contributing to the cell survival or cell death through apoptosis. Despite the number of carbon atoms in the fatty acid chain changes the physiological role; ceramides generally exert suppressive roles on the cell proliferation. There have been several enzymes identified in this pathway that are responsible for the conversion of ceramide into other sphingolipid derivatives. Those derivatives also have differential roles on those cellular processes. Sphingosine-1-phosphate is an example of such sphingolipid derivatives which has antiapoptotic effects. As they have significant impacts particularly on the cell death and survival, bioactive sphingolipids have a great potential to be targets in cancer therapy. Increasing number of studies indicates that sphingolipid derivatives are important in the progression of hematological malignancies, and they are also involved in the resistance to current chemotherapeutic options. This review compiles the current knowledge in this area for enlightening the therapeutic potentials of bioactive sphingolipids in various leukemias. © 2010 UICC.
URI: http://doi.org/10.1002/ijc.25478
http://hdl.handle.net/11147/2656
ISSN: 0020-7136
Appears in Collections:Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File Description SizeFormat 
2656.pdfİnceleme287.35 kBAdobe PDFThumbnail
View/Open
Show full item record

CORE Recommender

SCOPUSTM   
Citations

27
checked on Jul 24, 2021

WEB OF SCIENCETM
Citations

27
checked on Jul 24, 2021

Page view(s)

10
checked on Jul 24, 2021

Download(s)

16
checked on Jul 24, 2021

Google ScholarTM

Check

Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.